Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Leber's Hereditary Optic Neuropathy (LHON) – Double-blind Randomized Placebo-controlled Phase 2 Study
2006-002679-42Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Leber hereditary optic neuropathy (LHON) comparing Idebenone with Placebo (2 arms). Primary endpoint: Best recovery of logMAR visual acuity. Started Sep 2006; status: completed.
02
Drugs
idebenone
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on 2006-002679-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002679-42.